Intriguingly, elevated SLC7A11 expression has been reported to increase tumor cell vulnerability to disulfide stress, suggesting that activating disulfidptosis may represent a novel therapeutic strategy to overcome resistance and metastasis in OS [6]. This evidence concerns the gene SLC7A11 and neoplasm.